- 商品介绍
- 规格参数
- 包装参数
Biochem/physiol Actions
Potent cyclin-dependent kinase-like 5 inhibitor with additional potency against CDK9/16/17/18 and good kinome-wide selectivity.
SGC-CAF382-1 is a potent cyclin-dependent kinase-like 5 inhibitor (CDKL5 IC50 = 6.7 nM by binding assay & 10 nM by cellular NanoBRET) with additional potency against CDK9/16/17/18 (IC50 = 20/62/89/100 nM by cell-free enzymatic assay, 280/390/240/260 nM by cellular NanoBRET) and good kinome-wide selectivity. SGC-CAF382-1 downregulates EB2 Ser222 phosphorylation in DIV14-16 rat primary neurons (IC50 <5 nM) and in hippocampal slices from P20–30 rats ex vivo (IC50 <45 nM).
Disclaimer
Hygroscopic
| Quality Level | 100 |
| assay | ≥98% (HPLC) |
| form | powder |
| storage condition | desiccated |
| color | white to beige |
| solubility | DMSO: 2 mg/mL, clear |
| storage temp. | 2-8°C |
| SMILES string | O=C(NC1=NC=C(S1)SCC2=NC=C(O2)C(C)C)C3CCNCC3.[xTFA] |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
-
¥ 1596.77
-
¥ 1779.22
-
¥ 1866.29
-
¥ 3109.49
-
询价
-
询价
-
¥ 9737.84
-
¥ 3152.47
-
询价
-
询价
-
¥ 3372.68
-
¥ 8982.64
-
¥ 20380.83
-
¥ 2307.00
-
¥ 1301.36
-
¥ 3852.13
-
¥ 1196.14
-
¥ 2406.69
-
¥ 9909.51
-
¥ 4614.63
微信小程序
7X24小时在线咨询